Clinical trial data shows RAD 101 detects Brain Metastases

by admin February 10, 2025

February 10, 2025

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

Charbone Hydrogen Announces Q2 2024 Financial Results

RHI: Acqn of royalty over Sandstone Gold Project...

Siren Gold

Purepoint Uranium Enters into Option Agreement with Foran...

Cannabis Round-Up: Texas Attorney General Sues Local Cities...

New US Interior Secretary Moves to Expand Alaska...

Brightstar Completes Maiden Gold Pour

Freegold Intersects 4.63 g/t Au over 65.9 Metres...

Charbone Hydrogen Finalizes Arrangements with City of Sorel-Tracy...

Trident Royalties PLC Announces Court Sanction of Scheme...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

India and Pakistan both claim victory. But this latest conflict has no...
Anti-abortion provider measure in Trump’s ‘big, beautiful bill’ could spark House GOP rebellion
A bridge builder and quiet reformer. How Pope Leo will lead the Catholic Church
Acceleration of RAD204 Phase 1 dose escalation trial
Multiple New Multi-Commodity Targets

Categories

Business (1,634)
Investing (4,793)
Politics (7,565)
Uncategorized (2)
World (6,160)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

Clinical trial data shows RAD 101 detects Brain Metastases

MOU signed with Lafarge Canada Inc.

High-Grades up to 65g/t Au at Second Fortune Gold Mine

You may also like